BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.92% |
| 2 | Financials | 6.08% |
| 3 | Healthcare | 5.28% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
QCR Holdings
QCRH
$1.75B
| $92.9K | ﹤0.01% |
2,738
+2,734
| +68,350% | +$94K |
|
3052
Collegium Pharmaceutical
COLL
$918M
| $92.6K | ﹤0.01% |
6,116
+6,107
| +67,856% | +$97.8K |
|
|
MFGP
3053
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $92.4K | ﹤0.01% |
2,960
| – | – |
|
3054
York Water
YORW
$537M
| $92.2K | ﹤0.01% |
2,687
+2,664
| +11,583% | +$89.2K |
|
|
ACBI
3055
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $92K | ﹤0.01% |
5,162
+4,883
| +1,750% | +$90.1K |
|
|
SEI
3056
Solaris Energy Infrastructure
SEI
$4.15B
| $91.8K | ﹤0.01% |
5,585
+5,582
| +186,067% | +$85.6K |
|
3057
Nexa Resources
NEXA
$1.88B
| $91.6K | ﹤0.01% |
7,359
+3,627
| +97% | +$38.6K |
|
3058
KT
KT
$9.07B
| $91.2K | ﹤0.01% |
7,334
| – | – |
|
3059
Accuray
ARAY
$33.7M
| $91.1K | ﹤0.01% |
19,099
+17,917
| +1,516% | +$81.5K |
|
|
ANH
3060
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $91.1K | ﹤0.01% |
22,545
+11,080
| +97% | +$47.7K |
|
|
ATRS
3061
DELISTED
Antares Pharma, Inc.
ATRS
| $91.1K | ﹤0.01% |
30,053
+29,998
| +54,542% | +$97.2K |
|
3062
Standard BioTools
LAB
$285M
| $91K | ﹤0.01% |
6,849
+6,661
| +3,543% | +$70.2K |
|
|
RST
3063
DELISTED
ROSETTA STONE INC
RST
| $90.3K | ﹤0.01% |
4,132
+3,232
| +359% | +$56.4K |
|
3064
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $90.2K | ﹤0.01% |
836
-155,262
| -99% | -$16.4M |
|
3065
Shinhan Financial Group
SHG
$35.4B
| $90.1K | ﹤0.01% |
2,426
+1,497
| +161% | +$56.2K |
|
3066
Republic Bancorp
RBCAA
$1.93B
| $89.9K | ﹤0.01% |
2,010
+1,574
| +361% | +$66.7K |
|
|
PS
3067
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $89.8K | ﹤0.01% |
2,830
+1,703
| +151% | +$50.4K |
|
3068
Rigel Pharmaceuticals
RIGL
$783M
| $89.8K | ﹤0.01% |
3,494
+3,097
| +780% | +$70.8K |
|
3069
WillScot Mobile Mini Holdings
WSC
$4.34B
| $89.8K | ﹤0.01% |
8,093
+7,778
| +2,469% | +$80.8K |
|
|
AKCA
3070
DELISTED
Akcea Therapeutics Inc
AKCA
| $89.7K | ﹤0.01% |
3,165
+2,829
| +842% | +$82.4K |
|
|
HTB
3071
HomeTrust Bancshares
HTB
$836M
| $89.5K | ﹤0.01% |
3,550
+2,927
| +470% | +$78.2K |
|
|
OLP
3072
One Liberty Properties
OLP
$530M
| $89.2K | ﹤0.01% |
3,077
+2,513
| +446% | +$69.7K |
|
3073
NRC Health Common Stock
NRC
$465M
| $89.1K | ﹤0.01% |
2,309
+2,287
| +10,395% | +$89.6K |
|
|
CIVI
3074
DELISTED
Civitas Resources
CIVI
| $89.1K | ﹤0.01% |
3,925
+3,917
| +48,963% | +$90.3K |
|
|
TPIC
3075
DELISTED
TPI Composites
TPIC
| $89K | ﹤0.01% |
3,110
+3,046
| +4,759% | +$90.2K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.